Steven Gillis - 01 Jul 2026 Form 4 Insider Report for TAKEDA PHARMACEUTICAL CO LTD (TAK)

Reporting relationship: Director
Issuer ticker: TAK
Reported as of: 01 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jul 2026, 18:29:03 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Samuel Ntonme, by power of attorney, for Steven Gillis

Key filing fact

Steven Gillis filed Form 4 for TAKEDA PHARMACEUTICAL CO LTD (TAK) on 06 Jul 2026.

Key facts

This page summarizes Steven Gillis's Form 4 filing for TAKEDA PHARMACEUTICAL CO LTD (TAK).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 06 Jul 2026, 18:29.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001229592 Primary reporting owner

GILLIS STEVEN

Relationship: Director
Address: 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO
Signature: /s/ Samuel Ntonme, by power of attorney, for Steven Gillis
Signature date: 06 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TAK transaction

Ordinary Shares

Award

Transaction value
Shares: +3,800
Change %: +58%
Price: $0.000000^*
Shares after: 10,400
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F1, F2

TAK holding

American Depositary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 22,057
Date: 01 Jul 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TAK transaction Derivative

Tax Obligation Award

Disposed to Issuer

Transaction value
Shares: -1,152
Change %: -100%
Price: $4931.20^*
Shares after: 0
Date: 10 Jul 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,152
Exercise price
Footnotes: F3, F4

TAK transaction Derivative

Tax Obligation Award

Award

Transaction value
Shares: +1,319
Change %
Price: $0.000000^*
Shares after: 1,319
Date: 01 Jul 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,319
Exercise price
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029.

Footnote F2

Reflects the conversion of 3,100 Ordinary Shares into 6,200 American Depositary Shares upon vesting of RSUs.

Footnote F3

Each Tax Obligation Award was the economic equivalent of one Ordinary Share that, upon vest, was converted into to a cash payment primarily to cover tax obligations. Any remaining proceeds from the disposition of the associated Ordinary Shares will be delivered to the reporting person on July 10.

Footnote F4

The price reported in Column 8 is a weighted average price denominated in Yen. These shares were sold in transactions at prices ranging from JPY 4,883 to JPY 5,045, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Footnote F5

Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.